bioMérieux Statistics
Total Valuation
bioMérieux has a market cap or net worth of EUR 12.37 billion. The enterprise value is 12.54 billion.
Market Cap | 12.37B |
Enterprise Value | 12.54B |
Important Dates
The next estimated earnings date is Thursday, September 5, 2024.
Earnings Date | Sep 5, 2024 |
Ex-Dividend Date | Jun 7, 2024 |
Share Statistics
bioMérieux has 118.16 million shares outstanding. The number of shares has increased by 0.12% in one year.
Shares Outstanding | 118.16M |
Shares Change (YoY) | +0.12% |
Shares Change (QoQ) | -0.55% |
Owned by Insiders (%) | 0.05% |
Owned by Institutions (%) | 18.35% |
Float | 43.88M |
Valuation Ratios
The trailing PE ratio is 34.78 and the forward PE ratio is 25.53. bioMérieux's PEG ratio is 1.89.
PE Ratio | 34.78 |
Forward PE | 25.53 |
PS Ratio | 3.37 |
PB Ratio | 3.30 |
P/FCF Ratio | 115.51 |
PEG Ratio | 1.89 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.13, with an EV/FCF ratio of 117.07.
EV / Earnings | 35.06 |
EV / Sales | 3.41 |
EV / EBITDA | 14.13 |
EV / EBIT | 22.03 |
EV / FCF | 117.07 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 13.83.
Current Ratio | 2.03 |
Quick Ratio | 1.12 |
Debt / Equity | 13.83 |
Debt / EBITDA | 0.58 |
Debt / FCF | 4.84 |
Interest Coverage | 129.32 |
Financial Efficiency
Return on equity (ROE) is 8.73% and return on invested capital (ROIC) is 8.45%.
Return on Equity (ROE) | 8.73% |
Return on Assets (ROA) | 6.81% |
Return on Capital (ROIC) | 8.45% |
Revenue Per Employee | 268,305 |
Profits Per Employee | 26,110 |
Employee Count | 13,982 |
Asset Turnover | 0.70 |
Inventory Turnover | 1.97 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.54% in the last 52 weeks. The beta is 0.19, so bioMérieux's price volatility has been lower than the market average.
Beta (5Y) | 0.19 |
52-Week Price Change | +7.54% |
50-Day Moving Average | 96.23 |
200-Day Moving Average | 98.39 |
Relative Strength Index (RSI) | 73.05 |
Average Volume (20 Days) | 72,137 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, bioMérieux had revenue of EUR 3.67 billion and earned 357.60 million in profits. Earnings per share was 3.01.
Revenue | 3.67B |
Gross Profit | 2.06B |
Operating Income | 569.00M |
Pretax Income | 437.30M |
Net Income | 357.60M |
EBITDA | 857.80M |
EBIT | 569.00M |
Earnings Per Share (EPS) | 3.01 |
Balance Sheet
The company has 352.40 million in cash and 518.80 million in debt, giving a net cash position of -166.40 million or -1.41 per share.
Cash & Cash Equivalents | 352.40M |
Total Debt | 518.80M |
Net Cash | -166.40M |
Net Cash Per Share | -1.41 |
Equity (Book Value) | 3.75B |
Book Value Per Share | 31.76 |
Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was 445.40 million and capital expenditures -338.30 million, giving a free cash flow of 107.10 million.
Operating Cash Flow | 445.40M |
Capital Expenditures | -338.30M |
Free Cash Flow | 107.10M |
FCF Per Share | 0.91 |
Margins
Gross margin is 55.99%, with operating and profit margins of 15.48% and 9.73%.
Gross Margin | 55.99% |
Operating Margin | 15.48% |
Pretax Margin | 11.90% |
Profit Margin | 9.73% |
EBITDA Margin | 23.34% |
EBIT Margin | 15.48% |
FCF Margin | 2.91% |
Dividends & Yields
This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 0.81%.
Dividend Per Share | 0.85 |
Dividend Yield | 0.81% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 28.02% |
Buyback Yield | -0.12% |
Shareholder Yield | 0.69% |
Earnings Yield | 2.87% |
FCF Yield | 0.87% |
Stock Splits
The last stock split was on September 20, 2017. It was a forward split with a ratio of 3.
Last Split Date | Sep 20, 2017 |
Split Type | Forward |
Split Ratio | 3 |